Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q4 2014 (← Previous) (Next →)

Filing Date: Feb 17, 2015

Total Value: $1.704B (100.0% shares, 0.0% debt)

Holdings (46)

UTHR UNITED THERAPEUTICS CORP DEL 10.7%
Value $182M Shares 1,403,128 Est. Cost $75.71 Unrealized +70.2%
AUXILIUM PHARMACEUTICALS INC 9.9%
Value $169M Shares 4,915,931 Est. Cost $17.66 Unrealized
CUBIST PHARMACEUTICALS INC 7.7%
Value $131M Shares 1,303,668 Est. Cost $59.40 Unrealized
CLOVIS ONCOLOGY INC 6.9%
Value $118M Shares 2,102,857 Est. Cost $47.24 Unrealized
BMRN BIOMARIN PHARMACEUTICAL INC 6.9%
Value $118M Shares 1,302,197 Est. Cost $64.35 Unrealized +29.2%
ABIOMED INC 5.5%
Value $93.63M Shares 2,460,124 Est. Cost $21.84 Unrealized
CYBERONICS INC 5.3%
Value $89.54M Shares 1,608,101 Est. Cost $52.15 Unrealized
AMAG PHARMACEUTICALS INC 5.0%
Value $84.99M Shares 1,994,200 Est. Cost $26.16 Unrealized
ANACOR PHARMACEUTICALS INC 4.8%
Value $81.33M Shares 2,521,822 Est. Cost $13.71 Unrealized
INSM INSMED INC 4.2%
Value $71.56M Shares 4,625,648 Est. Cost $14.64 Unrealized -3.1%
WRIGHT MED GROUP INC 3.2%
Value $54.81M Shares 2,039,751 Est. Cost $28.27 Unrealized
VNDA VANDA PHARMACEUTICALS INC 3.2%
Value $54.23M Shares 3,786,908 Est. Cost $8.33 Unrealized +42.1%
NPS PHARMACEUTICALS INC 2.5%
Value $42.58M Shares 1,190,263 Est. Cost $27.84 Unrealized
KYTHERA BIOPHARMACEUTICALS I 2.3%
Value $38.91M Shares 1,121,884 Est. Cost $37.65 Unrealized
SEQUENOM INC 2.2%
Value $36.73M Shares 9,925,742 Est. Cost $3.91 Unrealized
CELLADON CORP 1.6%
Value $27.42M Shares 1,403,800 Est. Cost $11.92 Unrealized
CELGENE CORP 1.4%
Value $24.11M Shares 215,500 Est. Cost $92.73 Unrealized
STAA STAAR SURGICAL CO 1.4%
Value $23.96M Shares 2,629,622 Est. Cost $8.11 Unrealized +19.3%
GILD GILEAD SCIENCES INC 1.3%
Value $22.11M Shares 234,600 Est. Cost $59.95 Unrealized +19.9%
SHIRE PLC 1.1%
Value $18.19M Shares 85,600 Est. Cost $227.79 Unrealized
MOMENTA PHARMACEUTICALS INC 1.0%
Value $17.52M Shares 1,455,176 Est. Cost $14.44 Unrealized
ALIMERA SCIENCES INC 1.0%
Value $16.7M Shares 3,013,793 Est. Cost $4.88 Unrealized
FOLD AMICUS THERAPEUTICS INC 1.0%
Value $16.28M Shares 1,956,376 Est. Cost $3.07 Unrealized +123.3%
MEDIVATION INC 0.9%
Value $16.07M Shares 161,300 Est. Cost $82.41 Unrealized
ARIAD PHARMACEUTICALS INC 0.9%
Value $15.33M Shares 2,231,717 Est. Cost $6.82 Unrealized
PRTA PROTHENA CORP PLC 0.8%
Value $14.35M Shares 691,218 Est. Cost $22.18 Unrealized -5.9%
ACELRX PHARMACEUTICALS INC 0.8%
Value $14.32M Shares 2,128,539 Est. Cost $5.78 Unrealized
INTUITIVE SURGICAL INC 0.8%
Value $13.78M Shares 26,050 Est. Cost $433.70 Unrealized
ALGN ALIGN TECHNOLOGY INC 0.8%
Value $13.1M Shares 234,300 Est. Cost $52.61 Unrealized +0.5%
RIGEL PHARMACEUTICALS INC 0.7%
Value $11.75M Shares 5,176,319 Est. Cost $3.43 Unrealized
OREXIGEN THERAPEUTICS INC 0.7%
Value $11.7M Shares 1,931,324 Est. Cost $6.46 Unrealized
ZELTIQ AESTHETICS INC 0.6%
Value $11.01M Shares 394,486 Est. Cost $24.11 Unrealized
EXAS EXACT SCIENCES CORP 0.6%
Value $10.74M Shares 391,276 Est. Cost $12.83 Unrealized +89.6%
SALIX PHARMACEUTICALS INC 0.5%
Value $8.816M Shares 76,700 Est. Cost $114.94 Unrealized
THORATEC CORP 0.5%
Value $8.727M Shares 268,861 Est. Cost $32.46 Unrealized
QLT INC 0.4%
Value $6.95M Shares 1,733,208 Est. Cost $4.40 Unrealized
HISTOGENICS CORP 0.3%
Value $5M Shares 454,545 Est. Cost $11.00 Unrealized
XOMA CORP DEL 0.2%
Value $2.852M Shares 794,500 Est. Cost $4.07 Unrealized
BIOSPECIFICS TECHNOLOGIES CO 0.1%
Value $1.948M Shares 50,436 Est. Cost $34.45 Unrealized
HYPERION THERAPEUTICS INC 0.1%
Value $1.505M Shares 62,700 Est. Cost $22.00 Unrealized
INTREXON CORP 0.1%
Value $1.203M Shares 43,700 Est. Cost $27.53 Unrealized
CYTK CYTOKINETICS INC 0.1%
Value $991K Shares 123,686 Est. Cost $6.71 Unrealized -36.1%
AVEO PHARMACEUTICALS INC 0.0%
Value $562K Shares 669,449 Est. Cost $2.50 Unrealized
NXSTAGE MEDICAL INC 0.0%
Value $362K Shares 20,200 Est. Cost $17.92 Unrealized
MALLINCKRODT PUB LTD CO 0.0%
Value $355K Shares 3,588 Est. Cost $90.02 Unrealized
SOPHIRIS BIO INC 0.0%
Value $103K Shares 191,600 Est. Cost $3.88 Unrealized